Navigation Links
Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
Date:4/30/2008

e was accepted for review by the EMEA.

Also in February 2008, sanofi pasteur announced the signing of an agreement with Statens Serum Institut for the development and marketing of a new tuberculosis vaccine.

Net sales by geographic region

EURO million Q1 2008 net sales Change on a comparable basis

Europe 3,087 -0.7%

United States 2,170 -2.8%

Other Countries 1,680 +9.2%

TOTAL 6,937 0.8%

In Europe, the top line was adversely affected by a decline in net sales in France and Germany. The introduction of generics of Eloxatin(R) pared approximately 1.4% off growth for the period.

Net sales in the United States were 2.8% lower than in the first quarter of 2007, when Ambien(R) IR was not yet facing competition from generics. Excluding the impact of these generics, sales growth in the United States was 14.7%, in line with the performance recorded in the fourth quarter of 2007.

Net sales in the Other Countries region rose by 9.2%. Growth in the BRIC-M countries reached 12.5%.

2008 first-quarter adjusted consolidated income statement

In the first quarter of 2008, sanofi-aventis generated net sales of EURO 6,937 million, down 3.3% on a reported basis (0.8% on a comparable basis).

Gross profit was EURO 5,332 million. Other revenues rose by 10.9% to EURO 284 million, reflecting the strong performance of Plavix(R) in the United States. The ratio of cost of sales to net sales was 27.2%, 1.2 points higher than in the first quarter of 2007 (when Ambien(R) IR was not yet facing competition from generics).

Research and development expenses increased by 0.7% (or 4% excluding the effect of exchange rates).

Cost control led to a further reduction in the ratio of selling and general expenses to net sales, which fell to 25.
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Tubbs Jones Introduces Resolution Encouraging STD Prevention
2. New electronic health records demonstration project encouraging step says ACP
3. Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates
4. Digirad Corporation Reports Financial Results for First-Quarter 2008
5. Essilors 2008 First-Quarter Report
6. First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
7. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
8. Cynosure to Announce First-Quarter 2008 Financial Results on April 29
9. VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Abbott Hosts Conference Call for First-Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Soft and synthetic red-blood-cell-like particles carry oxygen, drugs, and more… ... ... -- Scientists at UC Santa Barbara, in collaboration with scientists ... mimic the characteristics and key functions of natural red blood ... , , , , ,The primary function of natural ...
(Date:12/14/2009)... The combination of AQUALIPO™ and NaturalFill™ revolutionary new liposuction and ... wrinkling, and plump lips all in one minimally invasive treatment. ... ... -- The combination of AQUALIPO™ and NaturalFill™ can remove excess ... and lips to help people slim down, reduce facial wrinkling ...
(Date:12/14/2009)... Mich., Dec. 14 Pepsi Bottling ... Commonwealth of Kentucky are among the major employers ... fall to help their employees make better decisions ... gives employees a personalized summary of their families, ... that care. With this personalized information, employees can ...
(Date:12/14/2009)... HOLLYWOOD, Fla., Dec. 14 Abbott ... a definitive agreement to acquire STARLIMS Technologies ... provider of laboratory information management systems, for ... The acquisition strengthens Abbott,s competitive position in ... applications to help laboratories efficiently store, retrieve ...
(Date:12/14/2009)... -- Americold Realty Trust ("Americold") announced today that it ... the U.S. Securities and Exchange Commission (the "SEC") relating ... shares. The number of shares to be offered and ... been determined. The common shares to be sold in ... ,, The joint book-running managers of the offering ...
Breaking Medicine News(10 mins):Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2
... BEVERLY HILLS, Calif., March 6 World-renowned,dermatologist, Dr. ... the public about,the dangers surrounding one of the ... Botox is the second-most recognized,prescription drug brand in ... many,instances, the use of Botox has replaced traditional ...
... Fund Insurance Company,of America recognizes Crissie Insurance Group ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070827/CLM117LOGO ), The ... number of independent,insurance agencies that work with Accident ... volume and profitability goals for the,previous year. Only ...
... rare hereditary disease where the immune system attacks the ... EU project, coordinated by Professor Olle Kmpe at Uppsala ... that opens new possibilities of understanding both APS-1 and ... the American journal The New England Journal of Medicine. ...
... March 6 The Neurologic & Orthopedic Hospital,of Chicago (NOHC) ... spine,surgery according to the Tenth Annual HealthGrades Hospital Quality in,America ... nation,s hospitals over the past three years. The study also,concluded ... in the state of Illinois -- A recipient ...
... LAUREL, N.J., March 6 MedQuist Inc.,(Pink Sheets: ... selected SpeechQ for Radiology(TM) as its front-end interactive ... "most connected healthcare,facilities" by Health Imaging & IT ... largest physician-owned practices in Tucson, with more than ...
... March 6 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... has entered into a,collaboration with one of the ... devices using PreMD,s innovative skin testing,technologies, to enhance ... name of the organization are not being disclosed ...
Other Medicine News:Health News:Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox 2Health News:Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox 3Health News:New protein discovery helps researchers understand autoimmune diseases 2Health News:Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery 2Health News:Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution 2Health News:PreMD Inc. Signs Agreement with Cosmetics Conglomerate 2
(Date:12/14/2009)... 2009 Frost & Sullivan European Product Quality Leadership ... SonoScape. The award recipient has effectively analyzed existing ... pricing, and portability - and introduced the S8 ... high-end colour Doppler HCU compares with that of ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, ...
(Date:12/14/2009)... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ... Notice of Allowance from the United States Patent ... patent application no. 11/060,641, which covers the composition ... sublingual tablet), the lead Transcept product candidate. ... than February 2025. ,, "This is the second ...
(Date:12/14/2009)... EXTON, Pa., Dec. 14 BioTrends Research ... Arthritis, a syndicated publication offering comprehensive insight ... report is based on a comparison of self-reported ... actual patient level data for over 1,000 RA ... agents. ,, To be eligible for the audit, ...
Breaking Medicine Technology:Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3California Shock Trauma Air Rescue 28CALSTAR 29 Leads the Way in Pioneering Helicopter Modification Which is Expected to Greatly Enhance Safety and S 50002 1California Shock Trauma Air Rescue 28CALSTAR 29 Leads the Way in Pioneering Helicopter Modification Which is Expected to Greatly Enhance Safety and S 50002 2California Shock Trauma Air Rescue 28CALSTAR 29 Leads the Way in Pioneering Helicopter Modification Which is Expected to Greatly Enhance Safety and S 50002 3Forsyth Medical Center 26apos 3Bs Derrick L Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast Growing Brain 49998 1Forsyth Medical Center 26apos 3Bs Derrick L Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast Growing Brain 49998 2Forsyth Medical Center 26apos 3Bs Derrick L Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast Growing Brain 49998 3New Study Shows that Prebiotics as Used by Jackson GI Medical Increases Lifespan by 33 25 4648 1New Study Shows that Prebiotics as Used by Jackson GI Medical Increases Lifespan by 33 25 4648 2
... ARBOR, Mich., July 18 Velcura Therapeutics, Inc.,CEO ... has joined,the Board of Directors of the biotechnology ... a powerful anti-inflammatory,agent stimulating bone formation and inhibiting ... a treatment for rheumatoid arthritis and,other bone diseases., ...
... 17 ,Pieris AG, a bio-pharmaceutical company developing ... therapeutics, and Wacker Biotech GmbH, a,full-service contract ... in the development of Pieris, PRS-050,Anticalin(R) for ... as a next generation VEGF antagonist and,as ...
Other Medicine Technology:Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors 2Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050 2
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The TVL-ADX lead is a thin, high-performing defibrillation lead that offers a true bipolar configuration designed for smarter sensing and low defibrillation threshold for greater patient safety margi...
... dual-electrode SPL defibrillator lead features ... offering the flexibility and maneuverability ... for the physician who prefers ... coils, the SPL lead also ...
... catheters feature 20 bipolar-spaced electrodes along ... degree of mapping resolution in atrial ... a 20-pole catheter enables more accurate ... with 10-pole catheter systems. The result: ...
Medicine Products: